Assembly Biosciences, Inc. revenue for the last year amounted to 7.16 M USD, the most of which — 7.16 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 6.25 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Assembly Biosciences, Inc. 7.16 M USD, and the year before that — 6.25 M USD.